Please login to the form below

Not currently logged in


This page shows the latest Seretide news and features for those working in and with pharma, biotech and healthcare.

AZ’s COPD triple data sets up market clash with GSK

AZ’s COPD triple data sets up market clash with GSK

GSK has a lot riding on Trelegy as it tries to restore growth in its respiratory business, which has been hit by patent expiries for two-drug COPD blockbuster Seretide/Advair

Latest news

More from news
Approximately 9 fully matching, plus 87 partially matching documents found.

Latest Intelligence

  • Back to the future Back to the future

    Only Seretide/Advair ($8.4bn), Abilify ($8bn) and Crestor ($6.9bn) prevented a biologic clean sweep of the bestsellers.

  • What can pharma learn from Olympic sports coverage? What can pharma learn from Olympic sports coverage?

    Over the years, the corporation has built a wealth of knowledge in the field, and built and maintained a leading portfolio of respiratory products from Ventolin in 1969 through to Seretide,

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
3 Monkeys Zeno

3 Monkeys Zeno is the UK arm of Zeno Group, a global integrated communications consultancy. Everything we do is rooted...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...